Anthem Bioscienc

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0CZ201020
  • NSEID: ANTHEM
  • BSEID: 544449
INR
651.75
-9.75 (-1.47%)
BSENSE

Dec 05

BSE+NSE Vol: 89.0 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Sep'24
Jun'24
Net Sales
550.03
540.21
483.20
524.96
338.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
550.03
540.21
483.20
524.96
338.59
Raw Material Cost
201.26
162.21
183.56
223.47
168.45
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
22.10
68.67
-6.72
-35.63
-21.94
Employee Cost
67.72
72.03
59.78
96.39
47.46
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
41.04
45.80
51.38
45.49
23.71
Total Expenditure (Excl Depreciation)
332.12
348.71
288.01
329.73
217.69
Operating Profit (PBDIT) excl Other Income
217.91
191.50
195.19
195.23
120.90
Other Income
48.23
22.81
14.06
27.85
19.46
Operating Profit (PBDIT)
266.14
214.31
209.25
223.08
140.36
Interest
3.03
1.61
0.52
3.55
3.71
Exceptional Items
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
263.11
212.70
208.73
219.53
136.65
Depreciation
33.50
26.45
30.42
19.99
18.68
Profit Before Tax
229.60
186.25
178.31
199.53
117.98
Tax
56.17
50.46
95.69
37.61
35.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
173.43
135.79
82.62
161.93
82.38
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
173.43
135.79
82.62
161.93
82.38
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
173.43
135.79
82.62
161.93
82.38
Equity Capital
112.32
112.32
111.82
112.32
111.82
Face Value
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.09
2.42
1.48
2.88
1.47
Diluted Earnings per share
3.09
2.42
1.47
2.84
1.47
Operating Profit Margin (Excl OI)
39.62%
35.45%
40.4%
37.19%
35.71%
Gross Profit Margin
47.84%
39.37%
43.2%
41.82%
40.36%
PAT Margin
31.53%
25.14%
17.1%
30.85%
24.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 2.64% vs 12.32% in Jun 2025

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 33.77% vs 21.03% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 15.47% vs -1.35% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 38.51% vs -23.33% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Anthem Bioscienc With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
550.03
979.94
-429.91
-43.87%
Other Operating Income
0.00
0.00
0.00
Total Operating income
550.03
979.94
-429.91
-43.87%
Raw Material Cost
201.26
115.13
86.13
74.81%
Purchase of Finished goods
0.00
232.72
-232.72
-100.00%
(Increase) / Decrease In Stocks
22.10
7.68
14.42
187.76%
Employee Cost
67.72
138.05
-70.33
-50.95%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
41.04
150.63
-109.59
-72.75%
Total Expenditure (Excl Depreciation)
332.12
644.21
-312.09
-48.45%
Operating Profit (PBDIT) excl Other Income
217.91
335.73
-117.82
-35.09%
Other Income
48.23
33.57
14.66
43.67%
Operating Profit (PBDIT)
266.14
369.30
-103.16
-27.93%
Interest
3.03
0.51
2.52
494.12%
Exceptional Items
0.00
2.64
-2.64
-100.00%
Gross Profit (PBDT)
263.11
371.43
-108.32
-29.16%
Depreciation
33.50
17.43
16.07
92.20%
Profit Before Tax
229.60
354.00
-124.40
-35.14%
Tax
56.17
96.51
-40.34
-41.80%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
173.43
257.49
-84.06
-32.65%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
173.43
257.49
-84.06
-32.65%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
173.43
257.49
-84.06
-32.65%
Equity Capital
112.32
169.41
-57.09
-33.70%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.09
15.20
-12.11
-79.67%
Diluted Earnings per share
3.09
15.02
-11.93
-79.43%
Operating Profit Margin (Excl OI)
39.62%
34.26%
0.00
5.36%
Gross Profit Margin
47.84%
37.90%
0.00
9.94%
PAT Margin
31.53%
26.28%
0.00
5.25%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 552.23 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 2.64% vs 12.32% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 5.21%

Quarterly - Standalone Net Profit
Standalone Net Profit 198.43 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 33.77% vs 21.03% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 16.52%

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 225.66 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 15.47% vs -1.35% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 12.37%

Quarterly - Interest
Interest 2.23 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 38.51% vs -23.33% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -12.89%

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 40.86%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024